Global Medical REIT Inc. Board Declares 2023 First Quarter Common and Preferred Dividends
Global Medical REIT (NYSE: GMRE) announced its 2023 first quarter cash dividends for common and preferred shares. The common cash dividend is set at $0.21 per share, payable on April 11, 2023, to stockholders of record as of March 24, 2023. Additionally, the Series A preferred dividend is $0.46875 per share, to be paid on May 1, 2023, for shareholders on record as of April 15, 2023. This reflects the company's ongoing commitment to return value to shareholders through consistent dividends.
- Declared a common dividend of $0.21 per share for Q1 2023.
- Series A preferred dividend of $0.46875 indicates financial stability.
- Dividends demonstrate a commitment to shareholder returns.
- None.
Common Dividend
The Board has declared the Company’s 2023 first quarter cash dividend of
Series A Preferred Dividend
The Board has also declared a quarterly cash dividend of
About
Forward-Looking Statements
This press release contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company’s control, which could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. These risks and uncertainties are described in greater detail in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended
View source version on businesswire.com: https://www.businesswire.com/news/home/20230310005126/en/
Investors:
Stephen.swett@icrinc.com
(203) 682-8377
Source: